Skip to main content
Back
LH logo

Labcorp Holdings Inc.

Data quality: 100%
LH
NYSE Healthcare Medical - Diagnostics & Research
$264.42
▲ $1.42 (0.54%)
Mkt Cap: 21.92B
Day Range
$264.35 $270.59
52-Week Range
$209.38 $293.72
Volume
439,069
50D / 200D Avg
$272.78 / $267.35
Prev Close
$263.00

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 25.0 0.4
P/B 2.5 2.9
ROE % 10.5 3.8
Net Margin % 6.3 3.9
Rev Growth 5Y % 1.5 10.0
D/E 0.8 0.2

Key Takeaways

Revenue grew 1.52% annually over 5 years — modest growth
Earnings grew 17.49% over the past year
ROE of 10.51% — decent returns on equity
Generating 1.21B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 5.73%
Cash machine — converts 137.59% of earnings into free cash flow

Growth

Revenue Growth (5Y)
1.52%
Revenue (1Y)7.25%
Earnings (1Y)17.49%
FCF Growth (3Y)17.46%

Quality

Return on Equity
10.51%
ROIC7.19%
Net Margin6.28%
Op. Margin10.87%

Safety

Debt / Equity
0.84
Current Ratio1.42
Interest Coverage6.77

Valuation

P/E Ratio
25.01
P/B Ratio2.54
EV/EBITDA18.86
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 7.25% Revenue Growth (3Y) 7.11%
Earnings Growth (1Y) 17.49% Earnings Growth (3Y) 44.81%
Revenue Growth (5Y) 1.52% Earnings Growth (5Y) -22.08%
Profitability
Revenue (TTM) 13.95B Net Income (TTM) 876.50M
ROE 10.51% ROA 4.77%
Gross Margin 26.75% Operating Margin 10.87%
Net Margin 6.28% Free Cash Flow (TTM) 1.21B
ROIC 7.19% FCF Growth (3Y) 17.46%
Safety
Debt / Equity 0.84 Current Ratio 1.42
Interest Coverage 6.77 Dividend Yield 0.01%
Valuation
P/E Ratio 25.01 P/B Ratio 2.54
P/S Ratio 1.57 PEG Ratio 1.28
EV/EBITDA 18.86 Dividend Yield 0.01%
Market Cap 21.92B Enterprise Value 28.59B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 13.95B 13.01B 12.16B 11.86B 13.14B
Net Income 876.50M 746.00M 418.00M 1.28B 2.38B
EPS (Diluted) 10.46 8.84 4.77 13.96 24.38
Gross Profit 3.73B 3.62B 3.36B 3.71B 4.99B
Operating Income 1.52B 1.09B 725.60M 1.44B 3.05B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 18.39B 18.38B 16.73B 20.16B 20.39B
Total Liabilities 9.76B 10.31B 8.83B 10.04B 10.09B
Shareholders' Equity 8.62B 8.05B 7.88B 10.10B 10.27B
Total Debt 7.20B 7.27B 5.95B 6.25B 6.34B
Cash & Equivalents 532.30M 1.52B 536.80M 320.60M 1.47B
Current Assets 4.02B 4.81B 3.77B 4.63B 5.33B
Current Liabilities 2.82B 3.33B 3.23B 3.08B 2.78B

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#613 of 1023
40

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026